Interdigital tinea pedis (dermatophytosis simplex and complex) and treatment with ciclopirox 0.77% gel

International Journal of Dermatology

Volumn 42, Issue SUPPL. 1, 2003, Pages 23-27

  Gupta, Aditya K ^a,b,c   Skinner, Alayne R ^b   Cooper, Elizabeth A ^b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b MEDIPROBE RESEARCH INC   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

10 UNDECENOIC ACID; ALLYLAMINE DERIVATIVE; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BUTENAFINE; CICLOPIROX; CLOTRIMAZOLE; CORTICOSTEROID; FLUCONAZOLE; IMIDAZOLE DERIVATIVE; ITRACONAZOLE; MICONAZOLE NITRATE; NAFTIFINE; OXICONAZOLE; PENICILLIN G; PLACEBO; SALICYLIC ACID; STREPTOMYCIN DERIVATIVE; TERBINAFINE; TOLCICLATE; TOLNAFTATE;

ADRENAL SUPPRESSION; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; BACTERIAL INFECTION; CLINICAL TRIAL; DERMATOMYCOSIS; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENTIATION; DRUG RESPONSE; GEL; HUMAN; ODOR; REVIEW; SIDE EFFECT; SKIN ATROPHY; SKIN INFLAMMATION; SUPERINFECTION; SYMPTOM; TINEA PEDIS; TOE;

EID: 0141705453     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.42.s1.1.x     Document Type: Review

References (35)

1. Masri-Fridling GD. Dermatophytosis of the feet. Derm Clin 1996; 14: 33-40.
2. Zuber TJ, Baddam K. Superficial fungal infection of the skin. Where and how it appears help determine therapy. Postgrad Med 2001; 109: 117-132.
3. Noble SL, Forbes RC, Stamm PL. Diagnosis and management of common tinea infections. Am Fam Phys 1998; 58: 163-174.
4. Rupke SJ. Fungal skin disorders. Dermatol 2000; 27: 407-421.
5. Gupta AK, Albreski D, Del Rosso JQ et al. The use of the new oral antifungal agents, itraconazole, terbinafine, and fluconazole, to treat onychomycosis and other dermatophytoses. Curr Probl Dermatol 2001; 13: 213-248.
6. Leyden JJ, Kligman AM. Interdigital athlete's foot: New concepts in pathogenesis. Postgrad Med 1977; 61: 112-116.
7. Leyden JJ. Tinea pedis pathophysiology and treatment. J Am Acad Dermatol 1994; 31: S31-S33.
8. Leyden JJ, Kligman AM. Interdigital athlete's foot. The interaction of dermatophytes and resident bacteria. Arch Dermatol 1978; 114: 1466-1472.
9. Leyden JJ. Progression of interdigital infections from simplex to complex. J Am Acad Dermatol 1993; 28: S7-S11.
10. Guttman C. Secondary bacterial infection often accompanies interdigital tinea pedis. Dermatol Times 1999; 4: S12.
11. Smith JMB. Interdigital athlete's foot: The battle for survival occurring between our toes. New Zealand Med J 1983; 26: 799-800.
12. Kates SG, Nordstrom KM, McGinley KJ, et al. Microbial ecology of interdigital infections of toe web spaces. J Am Acad Dermatol 1990; 22: 578-582.
13. Zaias N. Tinea pedis interdigitalis (interspace). Cutis 2001; 67: 28-31.
14. Reyes BA, Beutner KR, Cullen SI, et al. Butenafine, a fungicidal benzylamine derivative, used once daily for the treatment of interdigital tinea pedis. Int J Dermatol 1998; 37: 450-453.
15. Savin RC, De Villez RL, Elewski B, et al. One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: A multicenter, double-blind trial. J Am Acad Dermatol 1997; 36: S15-S19.
16. Tschen E, Elewski B, Gorsulowsky DC, et al. Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream. J Am Acad Dermatol 1997; 36: S9-S14.
17. Bergstresser PR, Elewski B, Hanifin J, et al. Topical terbinafine and clotrimazole in interdigital tinea pedis: A multicenter comparison of cure and relapse rates with 1- and 4-week treatment regimens. J Am Acad Dermatol 1993; 28: 648-651.
18. Berman B, Ellis C, Leyden JJ, et al. Efficacy of a 1-week, twice-daily regimen of terbinafine 1% cream in the treatment of interdigital tinea pedis. J Am Acad Dermatol 1992; 26: 956-960.
19. Ablon G, Rosen T, Spedale J. Comparative efficacy of naftifine, oxiconazole, and terbinafine in short-term treatment of tinea pedis. Int J Dermatol 1996; 35: 591-593.
20. Elewski B, Jones T, Zaias N. Comparison of an antifungal agent used alone with an antifungal used with a topical steroid in inflammatory tinea pedis. Cutis 1996; 58: 305-307.
21. Shellow WVR. 2% miconazole nitrate powder in aerosol spray form: Its efficacy in treating tinea pedis. J Int Med Res 1982; 10: 28-31.
22. Roberts DT, Bilsland DJ. Tinea pedis and skin dermatophytosis. In: Lebwohl M, Heymann WR, Berth-Jones J, Coulson I, eds. Treatment of Skin Disease. Comprehensive Therapeutic Strategies. Toronto: Harcourt Publishers Ltd, 2002: 624-626.
23. Gupta AK, Chow M, Daniel CR, Aly R. Treatments of tinea pedis. Dermatol Clin 2003; in press.
24. Gupta AK. Butenafine: An update of its use in superficial mycoses. Skin Ther Lett 2002; 7: 5.
25. Page JC, Abramson C, Lee W-L, et al. Diagnosis and treatment of tinea pedis: A review and update. J Am Podiatr Med Assoc 1991; 81: 304-316.
26. Anon. Loprox. Compendium of Pharmaceuticals and Specialties. Toronto: Webcom Ltd, 2002: 850.
27. Gupta AK. Ciclopirox: An overview. Int J Dermatol 2000; 40: 1-7.
28. Abrams BB, Hänel H, Hoehler T. Ciclopirox olamine: A hydroxypyridone antifungal agent. Clin Dermatol 1992; 9: 471-477.
29. Jue SG, Dawson GW, Brogden RN. Ciclopirox olamine 1% cream. A preliminary review of its antimicrobial activity and therapeutic use. Drugs 1985; 29: 330-341.
30. Lassus A, Nolting KS, Savopoulos C. Comparison of ciclopirox olamine 1% cream with ciclopirox 1%-hydrocortisone acetate 1% cream in the treatment of inflamed superficial mycoses. Clin Ther 1988; 10: 594-599.
31. Medicis. Loprox® Gel (Ciclopirox) 0.77%. Phoenix, AZ: Medicis, 2000.
32. Aly R, Fisher G, Katz I et al. Ciclopirox gel in the treatment of patients with interdigital tinea pedis. Int J Dematol 2003; 42 (Suppl. 1): 29-35.
33. Kligman AM, Bogaert H, Cordero C, et al. Evaluation of ciclopirox olamine cream for the treatment of tinea pedis: Multicenter, double-blind comparative studies. Clin Ther 1985; 7: 409-417.
34. Wu Y-C, Chuan M-T, Lü Y-C. Efficacy of ciclopiroxolamine 1% cream in onychomycosis and tinea pedis. Mycoses 1991; 34: 93-95.
35. Aly R, Maibach HI, Bagatell FK et al. Ciclopirox olamine lotion 1%: Bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis. Clin Ther 1989; 11: 290-303.